CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
61.74
+6.54 (11.85%)
At close: Feb 26, 2026, 4:00 PM EST
61.00
-0.74 (-1.20%)
After-hours: Feb 26, 2026, 4:45 PM EST
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$8,931
Profits / Employee
-$1,479,896
Market Cap
5.93B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 393 | -14 | -3.44% |
| Dec 31, 2023 | 407 | -51 | -11.14% |
| Dec 31, 2022 | 458 | -15 | -3.17% |
| Dec 31, 2021 | 473 | 63 | 15.37% |
| Dec 31, 2020 | 410 | 106 | 34.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,769 |
| PTC Therapeutics | 991 |
| Amicus Therapeutics | 499 |
| Immunovant | 362 |
| Cogent Biosciences | 258 |
| Structure Therapeutics | 218 |
| Apogee Therapeutics | 196 |
| Protagonist Therapeutics | 128 |
CRSP News
- 7 days ago - Crispr Therapeutics: Very High Risk But Even Higher Potential Reward - Seeking Alpha
- 8 days ago - CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript - Seeking Alpha
- 9 days ago - CRISPR Therapeutics Q4: The Elite Time To Buy Is In 2027 - Seeking Alpha
- 13 days ago - CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens - Benzinga
- 14 days ago - CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Crispr Therapeutics: Patience And Opportunity Through Volatility - Seeking Alpha
- 6 weeks ago - CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones - GlobeNewsWire